Order Article Reprints

Picchianti Diamanti A, Navarra A, Cuzzi G, Aiello A, Salemi S, Di Rosa R, De Lorenzo C, Vio D, Sebastiani G, Ferraioli M, et al. The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis. Biomedicines. 2023; 11(3):687. https://doi.org/10.3390/biomedicines11030687

Picchianti Diamanti, Andrea, Assunta Navarra, Gilda Cuzzi, Alessandra Aiello, Simonetta Salemi, Roberta Di Rosa, Chiara De Lorenzo, Daniele Vio, Giandomenico Sebastiani, Mario Ferraioli, and et al. 2023. "The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis" Biomedicines 11, no. 3: 687. https://doi.org/10.3390/biomedicines11030687

Picchianti Diamanti, A., Navarra, A., Cuzzi, G., Aiello, A., Salemi, S., Di Rosa, R., De Lorenzo, C., Vio, D., Sebastiani, G., Ferraioli, M., Benucci, M., Li Gobbi, F., Cantini, F., Polidori, V., Simmaco, M., Cialdi, E., Scolieri, P., Bruzzese, V., Nicastri, E., ... Goletti, D. (2023). The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis. Biomedicines, 11(3), 687. https://doi.org/10.3390/biomedicines11030687